Current Edition


New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma

Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled …

Continue Reading →

NHS England moves to fast-track clinical trials

NHS England has unveiled new processes designed to fast track clinical trials undertaken across the NHS, and boost access for patients. Working alongside the National …

Continue Reading →